Cognixion enrolls participants in NIH-funded BCI study for ALS
Cognixion Corporation announced it is now enrolling 30 adults with ALS in the CHOICE study, a 12-week trial comparing its investigational brain-computer interface with eye-tracking devices. The study is supported by the National Institute on Deafness and Other Communication Disorders and is registered on ClinicalTrials.gov as NCT07871071.
Primary source
Company press release (PR Newswire), November 4, 2026
Cognixion Now Enrolling NIH-Funded Study of Wearable Brain-Computer Interface Communication Device for People with ALS
Read the source: Cognixion Now Enrolling NIH-Funded Study of Wearable Brain-Computer Interface Communication Device for People with ALS prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation